US Broker Ratings

Exelixis, Inc. (EXEL) Stock Analysis: Evaluating Growth Potential in the Oncology Market

Exelixis, Inc. (EXEL), a prominent player in the biotechnology sector, continues to capture investor interest with its dedicated focus on developing innovative cancer treatments. With a market capitalization of $13.92..

ADMA Biologics Inc (ADMA) Stock Analysis: Exploring a 105.56% Potential Upside in the Booming Biotech Sector

In the ever-evolving landscape of biotechnology, ADMA Biologics Inc (NASDAQ: ADMA) presents a compelling case for investors eyeing growth opportunities in the healthcare sector. With a market capitalization of $1.92..

HealthEquity, Inc. (HQY) Stock Analysis: A Strong Buy with 25% Upside Potential

HealthEquity, Inc. (NASDAQ: HQY), a leading player in the Health Information Services industry, stands out as a compelling investment opportunity. With a market capitalization of $7.93 billion, this healthcare technology..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating a Stable Yet Competitive Landscape

Bio-Rad Laboratories, Inc. (NYSE: BIO) stands as a formidable player in the healthcare sector, particularly within the medical devices industry. With a robust market cap of $8.42 billion, Bio-Rad is..

Masimo Corporation (MASI) Stock Analysis: Evaluating Growth Potential in Healthcare Tech

Masimo Corporation (NASDAQ: MASI), a prominent player in the healthcare sector, has carved a niche in the medical devices industry by focusing on innovative patient monitoring technologies. With a market..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Healthcare Innovation with an 11.51% Upside Potential

IQVIA Holdings, Inc. (NYSE: IQV), a prominent player in the healthcare diagnostics and research industry, offers a compelling investment case for those seeking exposure to healthcare innovation and analytics. Based..

Chemed Corp (CHE) Stock Analysis: What Investors Need to Know About This Healthcare Giant’s Potential

Chemed Corp (NYSE: CHE), a stalwart in the healthcare sector, presents itself as a compelling investment opportunity with its robust business model and diverse service offerings. With a market capitalization..

Medtronic plc (MDT) Stock Analysis: Unlocking 17.58% Potential Upside with a Robust Dividend Yield

Medtronic plc (NYSE: MDT), a stalwart in the healthcare sector, particularly within the medical devices industry, continues to capture investor interest with its notable 17.58% potential upside. With a market..

AstraZeneca PLC (AZN) Stock Analysis: Exploring a 26% Potential Upside and Strong Buy Ratings

AstraZeneca PLC (NYSE: AZN), a stalwart in the healthcare sector, is commanding investor attention with its robust growth prospects and strategic positioning in the global pharmaceutical landscape. With a market..

Teva Pharmaceutical Industries (TEVA): Evaluating a 32.75% Potential Upside for Investors

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a major player in the global pharmaceutical landscape, is capturing investor attention with a compelling potential upside of 32.75%. With its current stock price..

Inspire Medical Systems (INSP) Stock Analysis: Exploring Growth Potential Amid Market Volatility

In the ever-evolving landscape of healthcare technology, Inspire Medical Systems, Inc. (NYSE: INSP) emerges as a notable player with a focus on innovative treatments for obstructive sleep apnea (OSA). As..

Charles River Laboratories (CRL) Stock Analysis: Navigating the Healthcare Research Frontier with a 1.92% Upside Potential

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a pivotal player in the healthcare sector, particularly within the diagnostics and research industry. With its market capitalization reaching $10.91 billion,..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: A 25% Potential Upside Amid Robust Revenue Growth

BridgeBio Pharma, Inc. (NASDAQ: BBIO) has emerged as a notable player in the healthcare sector, specifically within the biotechnology industry. With its headquarters in Palo Alto, California, the company is..

Teleflex Incorporated (TFX) Investor Outlook: Exploring a 11.81% Upside Potential in the Healthcare Sector

Teleflex Incorporated (NYSE: TFX) stands as a formidable player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $5.85 billion, Teleflex is..

ResMed Inc. (RMD) Stock Analysis: Exploring a 27% Upside Potential Amidst Robust Revenue Growth

ResMed Inc. (NYSE: RMD), a key player in the healthcare sector, specializes in medical instruments and supplies with a focus on respiratory disorders. The company, headquartered in San Diego, California,..

Molina Healthcare Inc (MOH) Stock Analysis: Navigating Healthcare Plans with a 5.44% Upside Potential

Molina Healthcare Inc (NYSE: MOH) stands as a prominent player in the healthcare plans industry, focusing on providing managed healthcare services primarily to low-income families and individuals across the United..

Option Care Health, Inc. (OPCH) Stock Analysis: Exploring a 29.66% Potential Upside

For investors eyeing opportunities in the healthcare sector, Option Care Health, Inc. (NASDAQ: OPCH) presents an intriguing proposition. As a key player in the medical care facilities industry, Option Care..

DexCom, Inc. (DXCM) Stock Analysis: A 20% Upside Potential with Strong Buy Ratings

DexCom, Inc. (DXCM), a trailblazer in the healthcare sector, specifically within the medical devices industry, has been making waves with its continuous glucose monitoring (CGM) systems. The company’s focus on..

Merit Medical Systems, Inc. (MMSI): Analyst Ratings Point to a 21% Upside in the Healthcare Sector

Merit Medical Systems, Inc. (NASDAQ: MMSI), a key player in the medical instruments and supplies industry, is garnering attention with its robust growth prospects and a notable analyst rating that..

Grifols, S.A. (GRFS) Stock Analysis: Exploring a Potential 43% Upside in the Healthcare Sector

Grifols, S.A. (NASDAQ: GRFS), a prominent player in the global healthcare sector, offers a promising opportunity for investors seeking exposure to the drug manufacturing industry. With a market capitalization of..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds